Tandem Diabetes Care, Inc. announced a multi-year collaboration agreement with the University of Virginia Center for Diabetes Technology (UVA). This partnership aims to advance research and development efforts on fully automated closed-loop insulin delivery systems. The collaboration will leverage UVA's expertise in translating advanced automated insulin delivery (AID) algorithms into medical devices and Tandem's market leadership in insulin delivery devices.
The research initiative will expand on Tandem’s ongoing work in automated insulin delivery technology, involving scientists, clinicians, and functional experts from both institutions. Tandem will provide research funding, technology, and supplies to the University of Virginia for diabetes-centered research and potential clinical studies. This strategic alliance is expected to accelerate the development of next-generation AID systems.
Results from this collaboration may lead to clinical research that could accelerate approved uses for Tandem’s future AID systems. This partnership underscores Tandem's commitment to innovation and its mission to improve the lives of people living with diabetes through advanced technology.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.